Royalty Pharma granted injuction as pursues Elan bid

DUBLIN, June 13 (Reuters) - Royalty Pharma was granted an injunction by the Irish High Court on Thursday that means its bid for Elan may not be doomed if some votes go against it at a meeting of the Irish drug company's shareholders next week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.